Negative Regulation of Interferon-β Gene Expression during Acute and Persistent Virus Infections
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Negative Regulation of Interferon-β Gene Expression during Acute and Persistent Virus Infections
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 6, Pages e20681
Publisher
Public Library of Science (PLoS)
Online
2011-06-04
DOI
10.1371/journal.pone.0020681
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The transcriptional code of human IFN-β gene expression
- (2010) Ethan Ford et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- SnapShot: Pathways of Antiviral Innate Immunity
- (2010) Lijun Sun et al. CELL
- NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways
- (2010) Jun Cui et al. CELL
- Negative Role of RIG-I Serine 8 Phosphorylation in the Regulation of Interferon-β Production
- (2010) Estanislao Nistal-Villán et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phosphorylation of RIG-I by Casein Kinase II Inhibits Its Antiviral Response
- (2010) Z. Sun et al. JOURNAL OF VIROLOGY
- Phosphorylation-Mediated Negative Regulation of RIG-I Antiviral Activity
- (2010) M. U. Gack et al. JOURNAL OF VIROLOGY
- Cardiac glycosides are potent inhibitors of interferon-β gene expression
- (2010) Junqiang Ye et al. Nature Chemical Biology
- The transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3
- (2010) Hwijin Kim et al. NATURE IMMUNOLOGY
- Type I interferons: crucial participants in disease amplification in autoimmunity
- (2010) John C. Hall et al. Nature Reviews Rheumatology
- Redefining Chronic Viral Infection
- (2009) Herbert W. Virgin et al. CELL
- A Nonself RNA Pattern: Tri-p to Panhandle
- (2009) Takashi Fujita IMMUNITY
- Common Threads in Persistent Viral Infections
- (2009) M. Kane et al. JOURNAL OF VIROLOGY
- PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4
- (2009) Fuping You et al. NATURE IMMUNOLOGY
- HIV pathogenesis: 25 years of progress and persistent challenges
- (2008) Jay A Levy AIDS
- Persistent Virus Infection Inhibits Type I Interferon Production by Plasmacytoid Dendritic Cells to Facilitate Opportunistic Infections
- (2008) Elina I. Zuniga et al. Cell Host & Microbe
- The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response
- (2008) Constantin S Friedman et al. EMBO REPORTS
- RNA recognition and signal transduction by RIG-I-like receptors
- (2008) Mitsutoshi Yoneyama et al. IMMUNOLOGICAL REVIEWS
- Select Paramyxoviral V Proteins Inhibit IRF3 Activation by Acting as Alternative Substrates for Inhibitor of κB Kinase ϵ (IKKe)/TBK1
- (2008) Lenette L. Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5
- (2008) Hiroki Kato et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IRF-3 Activation by Sendai Virus Infection Is Required for Cellular Apoptosis and Avoidance of Persistence
- (2008) K. Peters et al. JOURNAL OF VIROLOGY
- Mechanism of mda-5 Inhibition by Paramyxovirus V Proteins
- (2008) K. S. Childs et al. JOURNAL OF VIROLOGY
- NLRX1 is a regulator of mitochondrial antiviral immunity
- (2008) Chris B. Moore et al. NATURE
- Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections
- (2008) Judith N Mandl et al. NATURE MEDICINE
- Why is HIV a pathogen?
- (2008) Anna Forsman et al. TRENDS IN MICROBIOLOGY
- Chronic innate immune activation as a cause of HIV-1 immunopathogenesis
- (2007) Adriano Boasso et al. CLINICAL IMMUNOLOGY
- HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation
- (2007) Atsushi Okumura et al. VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started